Compare BMRN & BVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRN | BVN |
|---|---|---|
| Founded | 1996 | 1953 |
| Country | United States | Peru |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 8.8B |
| IPO Year | 1999 | 1997 |
| Metric | BMRN | BVN |
|---|---|---|
| Price | $58.97 | $29.70 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 1 |
| Target Price | ★ $88.22 | $44.00 |
| AVG Volume (30 Days) | ★ 1.9M | 1.3M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.78% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $15.02 | $29.99 |
| Revenue Next Year | $12.23 | N/A |
| P/E Ratio | $109.20 | ★ $21.78 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $49.26 | $16.06 |
| 52 Week High | $66.28 | $44.67 |
| Indicator | BMRN | BVN |
|---|---|---|
| Relative Strength Index (RSI) | 61.76 | 41.36 |
| Support Level | $53.32 | $29.17 |
| Resistance Level | $61.92 | $37.55 |
| Average True Range (ATR) | 1.49 | 1.50 |
| MACD | 0.19 | -0.29 |
| Stochastic Oscillator | 85.48 | 14.93 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Compania de Minas Buenaventura SAA is a Peruvian precious metals-producing company with experience in mine exploration, development, construction, and operation.